Cytosorbents (CTSO) Earnings Analysis
Cytosorbents (CTSO) next reports earnings on 2026-11-03, consensus EPS -0.02547 USD. Last quarter (2026-03-25) it missed with EPS -0.09 USD vs -0.05 USD est (-80%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E -2.05.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CTSO next report earnings?
| Next earnings date | 2026-11-03 |
|---|---|
| Consensus EPS estimate | -0.02547 USD |
| Revenue estimate | 0.01B |
CTSO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-25 | -0.09 USD | -0.05 USD | -80% | Miss |
| 2025-11-13 | -0.04 USD | -0.06 USD | +33.3% | Beat |
| 2025-08-07 | -0.05 USD | -0.07 USD | +28.6% | Beat |
| 2025-05-14 | -0.06 USD | -0.08 USD | +25% | Beat |
| 2025-03-31 | -0.03 USD | -0.07 USD | +57.1% | Beat |
Beat rate: 4/5 (80%) over reported quarters with consensus data.
CTSO valuation and analyst view
| Trailing P/E | -2.05 |
|---|---|
| Trailing EPS | -0.18886 USD |
| Price / book | 10.92 |
| Dividend yield | 0.00% |
| Market cap | 0.02B |
| Analyst consensus | Buy (12 buy / 1 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Cytosorbents (CTSO)'s next earnings date?
Cytosorbents is next scheduled to report on 2026-11-03, with a consensus EPS estimate of -0.02547 USD and revenue estimate of 0.01B.
Did CTSO beat earnings last quarter?
In its 2026-03-25 report, CTSO posted EPS of -0.09 USD versus a -0.05 USD estimate — a miss of 80%.
What is CTSO's earnings track record?
Over the last 5 reported quarters with consensus data, CTSO beat estimates 4 times (80%).
What is CTSO's current P/E ratio and EPS?
CTSO trades at a trailing P/E of -2.05 on trailing EPS of -0.1888623132848818 USD.
What do analysts rate CTSO?
Analyst consensus is "Buy" across 13 ratings (0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell).